1188800

Diclofenac sodium

United States Pharmacopeia (USP) Reference Standard

• Sinónimos: Diclofenac sodium salt, 2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid sodium salt
• Fórmula empírica (notación de Hill): C₁₄H₁₀Cl₂NNaO₂
• Número CAS: 15307-79-6
• Peso molecular: 318.13
• NACRES: NA.24
• PubChem Substance ID: 329749565
• UNSPSC Code: 41116107
• MDL number: MFCD00082251

Propiedades

• grade: pharmaceutical primary standard
• agency: USP
• API family: diclofenac
• manufacturer/tradename: USP
• application(s): pharmaceutical; pharmaceutical (small molecule)
• format: neat
• SMILES string: [Na+].[O-]C(=O)Cc1ccccc1Nc2c(Cl)cccc2Cl
• InChI: 1S/C14H11Cl2NO2.Na/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;/h1-7,17H,8H2,(H,18,19);/q;+1/p-1
• InChI key: KPHWPUGNDIVLNH-UHFFFAOYSA-M
• Gene Information: human ... PTGS1(5742), PTGS2(5743)

Descripción

General description

Find answers to frequently asked questions on USP products in USP FAQs.

Diclofenac sodium is a sodium salt of diclofenac, a non-steroidal anti-inflammatory drug (NSAID). It prevents the synthesis of prostaglandin involved in pain, inflammation, and fever by inhibiting the cyclooxygenase enzyme activity.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Diclofenac sodium USP reference standard suitable for use in specified USP compendial quality tests and assays.

Also used to prepare acid stage standard, standard, standard stock, sensitivity, and system suitability solution for the assay, impurity analysis, identification, and performance test by using liquid chromatography coupled with UV detector according to the given below monographs of United States Pharmacopeia (USP): 

• Diclofenac Sodium
• Diclofenac Sodium Delayed-Release Tablets  
• Diclofenac Sodium Extended-Release Tablets
• Diclofenac Sodium Topical Solution
• Diclofenac Sodium and Misoprostol Delayed-Release Tablets

Biochem/physiol Actions

Standard NSAID and cyclooxygenase (COX) inhibitor. Major metabolites are 4´-hydroxydiclofenac and 5´-hydroxydiclofenac. Has been used as substrate selective for CYP2C9.

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Información de seguridad

• Pictogramas: GHS06,GHS08,GHS09
• Palabra de advertencia: Danger
• Códigos de peligro: H301,H361d,H372,H411
• Hazard Classifications: Acute Tox. 3 Oral - Aquatic Chronic 2 - Repr. 2 - STOT RE 1
• Clase de almacenamiento: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• Punto de inflamación (°F): Not applicable
• Punto de inflamación (°C): Not applicable
• Indicaciones de precaución: P202 - P260 - P264 - P273 - P280 - P301 + P310